Pericardial involvement in systemic inflammatory diseases

Systemic inflammatory diseases (SIDs) are inflammatory syndromes with involvement of at least two organ systems. Classical SIDs include vasculitis, connective tissue diseases, and granulomatous diseases (box 1).1 The term ‘connective tissue disease’ is increasingly used to designate genetic conditions that affect the structural integrity of connective tissue, such as Marfan syndrome, and not only systemic inflammatory conditions. On this basis, the term ‘rheumatologic disease’ or ‘systemic autoimmune disease’ is adopted instead of ‘connective tissue disease’ in this review. Box 1 ### Main systemic inflammatory diseases #### Vasculitides #### Rheumatologic diseases (also known as connective tissue diseases) #### Granulomatous diseases #### Autoinflammatory diseases Cardiac involvement is not uncommon in SIDs, although major cardiac problems rarely present. Cardiac involvement may affect the pericardium (pericarditis and pericardial effusion), the myocardium (myocarditis, cardiomyopathy, rhythm and conduction disturbances, heart failure), coronary arteries (acute coronary syndromes, ischaemic heart disease), the endocardium (valvular disease, thrombi), and major vessels (aneurysm formation, arterial and venous thrombosis).1 2 The reported frequency of cardiac involvement is variable, depending on the applied diagnostic method and patient selection. Technological improvements in imaging and the increasing spread of diagnostic methods have revealed higher frequencies of cardiac abnormalities in patients with SIDs than in older autopsy studies. The pericardium consists of a double layered sac that provides mechanical protection, reduces the friction between the heart and surrounding structures, and limits the distension of the heart contributing to diastolic coupling of the ventricles. Normally, this function is achieved by the presence of a small amount of pericardial fluid (25–50 ml) produced by the visceral pericardium. Infectious and non-infectious noxa are usually responsible for inflammation of the pericardial layers, with increased production of …

[1]  Y. Adler,et al.  Risk of Constrictive Pericarditis After Acute Pericarditis , 2011, Circulation.

[2]  A. Brucato,et al.  Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis: Implications for the Diagnosis, Therapy, and Prognosis of Pericarditis , 2011, Circulation.

[3]  C. Baldari,et al.  Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. , 2010, Clinical and experimental rheumatology.

[4]  É. Marijon,et al.  Sarcoidosis: an unusual cause of acute pericarditis , 2010, Acta cardiologica.

[5]  Y. Adler,et al.  Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. , 2009, International journal of cardiology.

[6]  Y. Adler,et al.  Aetiological diagnosis in acute and recurrent pericarditis: when and how , 2009, Journal of cardiovascular medicine.

[7]  E. Oztekin,et al.  Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[8]  G. Brambilla,et al.  Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation , 2008, Circulation.

[9]  D. Knockaert Cardiac involvement in systemic inflammatory diseases. , 2007, European heart journal.

[10]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[11]  A. Voskuyl The heart and cardiovascular manifestations in rheumatoid arthritis. , 2006, Rheumatology.

[12]  I. Lundberg,et al.  Cardiac involvement in autoimmune myositis and mixed connective tissue disease , 2005, Lupus.

[13]  A. Doria,et al.  Behçet’s disease and cardiovascular involvement , 2005, Lupus.

[14]  T. Miller,et al.  Cardiac involvement in systemic lupus erythematosus. , 1999, Mayo Clinic proceedings.

[15]  A. Freemont,et al.  Pericardial involvement in systemic sclerosis , 1997, Annals of the rheumatic diseases.

[16]  M. Gyöngyösi,et al.  Cardiac manifestations in primary Sjögren's syndrome. , 1996, Annals of the rheumatic diseases.

[17]  E. Treadwell,et al.  Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. , 1994, Journal of the National Medical Association.

[18]  E. Raz,et al.  [Cardiac involvement in systemic lupus erythematosus]. , 1991, Harefuah.

[19]  D. Spodick,et al.  Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .

[20]  Y. Adler,et al.  Medical therapy of pericardial diseases Part II : Noninfectious pericarditis , pericardial effusion and constrictive pericarditis , 2010 .

[21]  M. Yacoub,et al.  [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. , 2004, Revista espanola de cardiologia.

[22]  T. Takahashi [Erythematosus]. , 1971, Nihon rinsho. Japanese journal of clinical medicine.